Patent directory · USPTO A61K / A61P
Patents matching “Protagonist Therapeutics, Inc.”
32 pharma patents match "Protagonist Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 32 pharmaceutical patents matching "Protagonist Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10030061
Hepcidin analogues and uses thereof
granted -
US 10023614
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 9822157
Hepcidin analogues and uses thereof
granted -
US 9809623
α4β7 peptide monomer and dimer antagonists
granted -
US 9714270
a4B7 integrin thioether peptide antagonists
granted -
US 9624268
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 9518091
A4B7 peptide monomer and dimer antagonists
granted -
US 9273093
α4β7 peptide dimer antagonists
granted